Evidence map›Paper›PMID 32203104›Full record

ReviewExperimental & molecular medicine2020

Protein disulfide isomerase in cardiovascular disease.

Bei Xiong, Vishwanath Jha, Jeong-Ki Min, Jaehyung Cho

Open access · goldAbstract readReview
In one paragraph

Review in Experimental & molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. How Electricity Prevents Us from Bleeding to Death.Reviews of physiology, biochemistry and pharmacology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Progress of nanomaterials in the treatment of thrombus.Drug delivery and translational research · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Bei XiongDepartment of Pharmacology, University of Illinois-Chicago College of Medicine, Chicago, IL, 60612, USA.
Vishwanath JhaDepartment of Pharmacology, University of Illinois-Chicago College of Medicine, Chicago, IL, 60612, USA.
Jeong-Ki MinBiotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Jaehyung ChoDepartment of Pharmacology, University of Illinois-Chicago College of Medicine, Chicago, IL, 60612, USA. thromres@uic.edu.ORCID http://orcid.org/0000-0003-2404-3446
Illinois College · USKorea Research Institute of Bioscience and Biotechnology · KRUniversity of Illinois Chicago · USWuhan University · CN

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Thiol isomerases in neutrophil recruitment and thromboinflammatory diseaseR01HL130028 · NHLBI · WASHINGTON UNIVERSITY · PI CHO, JAEHYUNG · 2016 to 2024
$3.6M
Thiol isomerases and ERO1α in sickle cell vaso-occlusionR01HL148280 · NHLBI · WASHINGTON UNIVERSITY · PI CHO, JAEHYUNG · 2019 to 2022
$1.9M
Ero1α in platelet activity and thrombosisR01HL146559 · NHLBI · WASHINGTON UNIVERSITY · PI CHO, JAEHYUNG · 2020 to 2023
$1.7M
NCATS NIH HHS UL1 TR002003NHLBI NIH HHS R01 HL130028NHLBI NIH HHS R01 HL146559NHLBI NIH HHS R01 HL148280
6 · The paper itself

Abstract

Protein disulfide isomerase (PDI) participates in the pathogenesis of numerous diseases. Increasing evidence indicates that intravascular cell-derived PDI plays an important role in the initiation and progression of cardiovascular diseases, including thrombosis and vascular inflammation. Recent studies with PDI conditional knockout mice have advanced our understanding of the function of cell-specific PDI in disease processes. Furthermore, the identification and development of novel small-molecule PDI inhibitors has led into a new era of PDI research that transitioned from the bench to bedside. In this review, we will discuss recent findings on the regulatory role of PDI in cardiovascular disease.

Indexed as

AnimalsCardiovascular DiseasesHumansMice, KnockoutProtein Disulfide-IsomerasesThrombosisProtein Disulfide-Isomerases

Identifiers

PMID32203104
PMCPMC7156431
OpenAlexW3011943017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.